177 related articles for article (PubMed ID: 28858522)
1. Chemical Editing of Macrocyclic Natural Products and Kinetic Profiling Reveal Slow, Tight-Binding Histone Deacetylase Inhibitors with Picomolar Affinities.
Kitir B; Maolanon AR; Ohm RG; Colaço AR; Fristrup P; Madsen AS; Olsen CA
Biochemistry; 2017 Sep; 56(38):5134-5146. PubMed ID: 28858522
[TBL] [Abstract][Full Text] [Related]
2. Natural and Synthetic Macrocyclic Inhibitors of the Histone Deacetylase Enzymes.
Maolanon AR; Kristensen HM; Leman LJ; Ghadiri MR; Olsen CA
Chembiochem; 2017 Jan; 18(1):5-49. PubMed ID: 27748555
[TBL] [Abstract][Full Text] [Related]
3. Natural products as zinc-dependent histone deacetylase inhibitors.
Tan S; Liu ZP
ChemMedChem; 2015 Mar; 10(3):441-50. PubMed ID: 25581683
[TBL] [Abstract][Full Text] [Related]
4. Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity.
Auzzas L; Larsson A; Matera R; Baraldi A; Deschênes-Simard B; Giannini G; Cabri W; Battistuzzi G; Gallo G; Ciacci A; Vesci L; Pisano C; Hanessian S
J Med Chem; 2010 Dec; 53(23):8387-99. PubMed ID: 21073160
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in the development of histone deacetylase inhibitors as anti-cancer agents.
Zhang L; Lei J; Shan Y; Yang H; Song M; Ma Y
Mini Rev Med Chem; 2013 Dec; 13(14):1999-2013. PubMed ID: 24160707
[TBL] [Abstract][Full Text] [Related]
6. The effect of various zinc binding groups on inhibition of histone deacetylases 1-11.
Madsen AS; Kristensen HM; Lanz G; Olsen CA
ChemMedChem; 2014 Mar; 9(3):614-26. PubMed ID: 24375963
[TBL] [Abstract][Full Text] [Related]
7. Peptide based macrocycles: selective histone deacetylase inhibitors with antiproliferative activity.
Rajak H; Singh A; Dewangan PK; Patel V; Jain DK; Tiwari SK; Veerasamy R; Sharma PC
Curr Med Chem; 2013; 20(14):1887-903. PubMed ID: 23409715
[TBL] [Abstract][Full Text] [Related]
8. HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.
Sangwan R; Rajan R; Mandal PK
Eur J Med Chem; 2018 Oct; 158():620-706. PubMed ID: 30245394
[TBL] [Abstract][Full Text] [Related]
9. Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships.
Poli G; Di Fabio R; Ferrante L; Summa V; Botta M
ChemMedChem; 2017 Dec; 12(23):1917-1926. PubMed ID: 29117473
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254
[TBL] [Abstract][Full Text] [Related]
11. Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2.
Ning CQ; Lu C; Hu L; Bi YJ; Yao L; He YJ; Liu LF; Liu XY; Yu NF
Eur J Med Chem; 2015 May; 95():104-15. PubMed ID: 25800646
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and activity of some new histone deacetylases inhibitors].
Cheng YH; Guo YS; Han HZ; Wang N; Zhang GH; Guo ZR; Wu S
Yao Xue Xue Bao; 2010 Jun; 45(6):735-41. PubMed ID: 20939182
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors.
Liu R; Wang J; Tang W; Fang H
Bioorg Med Chem; 2016 Apr; 24(7):1446-54. PubMed ID: 26907204
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy.
Gong CJ; Gao AH; Zhang YM; Su MB; Chen F; Sheng L; Zhou YB; Li JY; Li J; Nan FJ
Eur J Med Chem; 2016 Apr; 112():81-90. PubMed ID: 26890114
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
[TBL] [Abstract][Full Text] [Related]
16. Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase.
Moreno-Yruela C; Galleano I; Madsen AS; Olsen CA
Cell Chem Biol; 2018 Jul; 25(7):849-856.e8. PubMed ID: 29731425
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.
Tashima T; Murata H; Kodama H
Bioorg Med Chem; 2014 Jul; 22(14):3720-31. PubMed ID: 24864038
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 1, 3-disubstituted-pyrazole derivatives as new class I and IIb histone deacetylase inhibitors.
Yao Y; Liao C; Li Z; Wang Z; Sun Q; Liu C; Yang Y; Tu Z; Jiang S
Eur J Med Chem; 2014 Oct; 86():639-52. PubMed ID: 25218912
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of mono and bicyclic tetrapeptides thioester as potent inhibitor of histone deacetylases.
Hoque MA; Islam MS; Islam MN; Kato T; Nishino N; Ito A; Yoshida M
Amino Acids; 2014 Oct; 46(10):2435-44. PubMed ID: 25048030
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors.
Thaler F; Varasi M; Abate A; Carenzi G; Colombo A; Bigogno C; Boggio R; Zuffo RD; Rapetti D; Resconi A; Regalia N; Vultaggio S; Dondio G; Gagliardi S; Minucci S; Mercurio C
Eur J Med Chem; 2013 Jun; 64():273-84. PubMed ID: 23644210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]